City Therapeutics, Inc.

NAS:CTYHealth Technology

$21.46−4.20%At closeAt close · Tue 20 Oct · ≈ AED 78.81 · Market cap $1.08B

USD millions	FY2024	FY2025
Revenue	2.8	13.6
Cost of revenue	0.4	1.2
Gross profit	2.4	12.4
Research & development	25.7	58.4
Operating expenses	31.4	72.3
Operating income	(29.1)	(59.9)
Interest expense	0.4	2.3
Interest income	2.4	4.2
Pre-tax income	(27.8)	(58.5)
Income tax	0.0	0.0
Net income	(27.8)	(58.5)
EPS, basic (per share)	(0.55)	(1.16)
EPS, diluted (per share)	(0.55)	(1.16)
EBITDA	(28.7)	(58.8)
Depreciation & amortization	0.4	1.2
Weighted average shares (shares)	50,332,279	50,332,279
Weighted average diluted shares (shares)	50,332,279	50,332,279
Gross margin	84.7%	91.4%
Operating margin	−1,047.2%	−441.8%
Net margin	−1,002.0%	−431.4%

USD millionsUpdated 31 Dec 2025 ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.